X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5%
Wed, 30 Jan

STRIDES PHARMA SCIENCE has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m7,4907,3267,9458.4%6.1%
Other incomeRs m157778-89.3%-94.7%
TurnoverRs m7,6477,4047,9537.4%4.0%
ExpensesRs m6,2626,3306,6745.4%6.6%
Gross profitRs m1,1669221,27838.6%9.7%
DepreciationRs m391445407-8.6%4.1%
InterestRs m4984855013.3%0.6%
Profit before taxRs m43470379443.8%-12.6%
TaxRs m-21663293.2%
Profit after taxRs m43554316489.0%-27.5%
Gross profit margin%15.612.616.1
Effective tax rate%-0.423.116.7
Net profit margin%5.70.74.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 6.1% on a year-on-year (YoY) basis. The expenses were up by 6.6% YoY during the same period.
  • The company's operating profit increased by 9.7% YoY during the quarter. Consequently, operating profit margins remained same and stood at 16.1% in 3QFY19.
  • Depreciation charges increased by 4.1% and finance costs increased by 0.6% YoY, respectively.
  • Other income declined by 94.7% YoY during the quarter.
  • Net profit for the quarter declined by 27.5% YoY. Net profit margins during the quarter declined from 5.7% in 3QFY18 to 4.0% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.4% QoQ during the same period.
  • The company's operating profit increased by 38.6% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 16.1% in 3QFY19 as against 12.6% in 2QFY18.
  • Net profit for the quarter increased by 489.0% QoQ, while net profit margins increased from 0.7% in 2QFY18 to 4.0% in 3QFY19.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters, please visit here.

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year, STRIDES PHARMA SCIENCE share price has moved up from Rs 785.6 to Rs 503.7, registering a Loss of Rs 281.9 or around 35.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,736.9 (down 0.2%). Over the last one year it has moved down from 14,799.8 to 13,736.9, a gain of 1,063 points (down 7.2%).

Overall, the S&P BSE SENSEX is down 1.9% over the year.

Current Valuations

At the current price of Rs 503.7, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 72.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.2 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY19); Net Profit Down 72.2% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 54 m (down 72.2% YoY). Sales on the other hand came in at Rs 7 bn (down 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Driverless Cars are Here. And This Tiny Company is in the Lead...(The 5 Minute Wrapup)

Jul 17, 2019

This future-ready company thrives on the pace of technological change.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Jul 23, 2019 03:35 PM

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - ALEMBIC LTD COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS